CVS Health Corp. stock trades at EUR 77.66, volume 24.6 percent below average

Published on 10/09/2026 at 19:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At EUR 77.66 on October 9, 2026, CVS Health Corp. stock stood above EUR 75.61. Market cap was USD 110.8 billion, with a USD 110.68 52-week high.

Key points in brief

CVS Health Corp. stock traded at EUR 77.66 at Lang & Schwarz on October 9, 2026, versus a EUR 75.61 prior close.
The EUR 77.66 quote was 24.59 percent below the average volume benchmark in the primary-market data.
CVS Health had a USD 110.8 billion market capitalization, a 22.99 P/E ratio and a USD 69.51 to USD 110.68 52-week range.
CVS Health is scheduled to discuss third-quarter 2026 results on November 4, 2026, at 8:00 a.m. ET.

Aquarellbild eines amerikanischen Gesundheitszentrums mit Bäumen und Parkplatz in Pastellfarben — CVS Health Corp. Aquarell-Illustration zeigt amerikanisches Gesundheitszentrum im sonnigen Vorort, ISIN US1266501006, Illustration mit AI erstellt.

CVS Health Corp. (ISIN US1266501006) traded at EUR 77.66 at Lang & Schwarz on October 9, 2026 at 7:24 p.m. CEST, versus a EUR 75.61 prior close. The after-hours quote puts the stock 2.71 percent above its Lang & Schwarz reference close.

Volume stays below average

Trading volume on the primary market was 6,000,844 shares on October 9, 2026, compared with an average volume of 7,957,851 shares. That places the session volume 24.59 percent below its average, a useful liquidity marker as the euro quote moved higher after the Xetra close.

The Lang & Schwarz bid was EUR 77.62 and the ask was EUR 77.70 at 7:24 p.m. CEST. The 3.39 percent spread between the bid and ask, measured against the bid, was EUR 0.08 and frames the immediate after-hours trading range.

Wide yearly trading range

On the NYSE, CVS Health was last quoted at USD 86.86 on October 9, 2026 at 1:28 p.m. ET. The primary-market quote was down 1.06 percent from its prior session level, a separate currency and venue measure from the euro price.

The USD 69.51 to USD 110.68 52-week range leaves the primary-market quote USD 23.82 below its high and USD 17.35 above its low. The range is wide enough to make the current position more informative than a single daily move.

Valuation and next date

CVS Health had a market capitalization of USD 110.8 billion and a P/E ratio of 22.99 on October 9, 2026. Its trailing dividend yield was 3.00 percent, while the latest quote remained below the 52-week high in the primary-market currency.

MarketBeat reported on October 6, 2026 that 22 of 23 analysts rated CVS Health a Buy and that the average 12-month target was USD 107.24. The same report said the quarterly dividend was USD 0.6650, equivalent to a 3.10 percent annualized yield.

CVS Health announced on October 5, 2026 that it will discuss third-quarter 2026 financial results on November 4, 2026, at 8:00 a.m. ET. The scheduled date is the next clear calendar marker for the stock.

Comparison with peers

CVS Health Corp.: plus 2.71 percent, P/E 22.99, market capitalization USD 110.8 billion
UnitedHealth Group (NYSE, USD): plus 1.76 percent, P/E 24.30, market capitalization USD 342.8 billion
Cigna (NYSE, USD): plus 0.35 percent, P/E 11.67, market capitalization USD 74.5 billion

After-hours price check

CVS Health's EUR 77.66 quote at Lang & Schwarz was above the EUR 75.61 prior close on October 9, 2026 at 7:24 p.m. CEST. The euro price, the primary-market quote and the peer figures use separate currencies or venues and are not combined into one performance measure.

The further course of trading is shown by the continuously updated real-time quote of CVS Health Corp. stock.